That is the equivalent of a half a penny on nearly 3 million p/s shares. With a much lower share count, it will be easy to jerk the share price around. Take advantage of it when/if you can! This is all noise for now ...
So as a rookie, he is hired by a department with a less than stellar record. That's enough to disparage his character? Good thing Mike Brown isn't supposed to be judged by HIS behavior prior to the event, huh? You can't have it both ways!!
This volume is probably due to the new article on Lanza ... you're right book ... this is just a test run! But, so far, there's been very little profit taking even after last week's under the radar run.
Pull back is on diminishing volume. I figured $23-ish would be the bottom of the pullback. Started adding some this a.m.
That guy has been on ignore for me since his first day posting ... like a breath of fresh air!
If shares are in a margin account, they CAN be borrowed. They have to be in a cash account.
It appears that the momo shorts piled on and with the low float can inflict maximum pain. I was one of the Ebola crowd, but only bought a few and have been waiting for this pullback to establish a longer term position.
From Bloomberg ... read any of the links on the Yahoo page. It's been in the news!!
A vaccine that could help protect medical workers as they fight Ebola in West Africa, even in the minutes after an accidental infection, may take at least a month to be available as global officials weigh its safety.
The sudden donation of as many as 1,000 doses of a vaccine that hasn’t been tested in humans is creating a conundrum because they could go to healthy people, rather than those already infected. Earlier, the World Health Organization decided that people in West Africa should be allowed access to promising experimental treatments or vaccines.
Possible while news isn't focused on ebola ... but TKMR was driven down to about 16 last week before rebounding, too. The low float will make this very volatile. I've got a "plan" ... lol There is a real story here, not just ebola.
Get real ... it's a low float stock so it's volatile. That 2.5% move down was on 50K shares. And, you spend WAY too much time watching it! Talk about disgusting low lifes!!
Ok, you've made your point! Move along, nothing to see here!!!
Another positive is that TheStreet ranks NLNK a "sell". So, there shouldn't be any Cramerisms coming this way! Admittedly, I found my way to NLNK because of the Ebola news, but after looking into it, took a position last Friday a.m. The share structure/float makes this a screaming buy on any good news, and it had definitely over-corrected along with the biotech sell off. Risk/reward still looks good at this level, imo.